High Systemic Immune-Inflammation Index Predicts Poor Survival in Patients with Human Epidermal Growth Factor Receptor-2 Positive Breast Cancer Receiving Adjuvant Trastuzumab
Li Jiang, 1, 2 Jianjiang Fang, 2 Jinhua Ding 3 1Department of General Practice, Ningbo Medical Center Lihuili Hospital/Taipei Medical University Ningbo Medical Center, Ningbo, Zhejiang 315000, People’s Republic of China; 2Department of Emergency, Ningbo Medical Center Lihuili Hospital/Ta...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2020-01-01
|
| Series: | Cancer Management and Research |
| Subjects: | |
| Online Access: | https://www.dovepress.com/high-systemic-immune-inflammation-index-predicts-poor-survival-in-pati-peer-reviewed-article-CMAR |